Tuesday’s Daily Piece: Additional Rapid Acting Insulin Option for Children with Diabetes

Insulin aspart with niacinamide (Fiasp) is now approved for use in pediatric (children) with diabetes. Niacinamide allows for faster absorption of insulin aspart. Fiasp was approved in 2017, and expanded to use in insulin pumps in 2019. Excited to have another rapid acting insulin analog options for children. To learn more, please click below.

https://www.medscape.com/viewarticle/923435

Image result for fiasp
This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#children #diabetes #insulin #Fiasp

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.

Leave a Reply

Your email address will not be published. Required fields are marked *